1 |
Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000;80:717-766.
DOI
|
2 |
Masuyer G, Conrad J, Stenmark P. The structure of the tetanus toxin reveals pH-mediated domain dynamics. EMBO Rep 2017;18:1306-1317.
DOI
|
3 |
Giannini L, Maccari A, Chiesa V, Canevini MP. Trismus, the first symptom in a challenging diagnosis of tetanus. BMJ Case Rep 2016;2016:bcr2015213897.
|
4 |
Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth 2001;87:477-487.
DOI
|
5 |
Kyu HH, Mumford JE, Stanaway JD, et al. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health 2017;17:179.
DOI
|
6 |
Scully C. Trismus. In: Scully C, ed. Oral and maxillofacial medicine: the basis of diagnosis and treatment. 3rd ed. St. Louis: Elsevier Health Sciences; 2013. pp. 167-169.
|
7 |
Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35:337-342.
DOI
|
8 |
Thomas F, Ozanne F, Mamelle G, Wibault P, Eschwege F. Radiotherapy alone for oropharyngeal carcinomas: the role of fraction size (2 Gy vs 2.5 Gy) on local control and early and late complications. Int J Radiat Oncol Biol Phys 1988;15:1097-1102.
DOI
|
9 |
Dhanrajani PJ, Jonaidel O. Trismus: aetiology, differential diagnosis and treatment. Dent Update 2002;29:88-92, 94.
DOI
|
10 |
Okeson JP. Diagnosis of tempormandibular disorders. In: Okeson JP, ed. Management of temporomandibular disorders and occlusion. 8th ed. St. Louis: Elsevier Health Sciences; 2019. pp. 223-258.
|
11 |
Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 8th ed. Washington, DC: Department of Health & Human Services, Public Health Foundation; 2005.
|
12 |
Weng WC, Huang WY, Peng TI, et al. Clinical characteristics of adult tetanus in a Taiwan medical center. J Formos Med Assoc 2011;110:705-710.
DOI
|
13 |
Surana S, Tosolini AP, Meyer IFG, Fellows AD, Novoselov SS, Schiavo G. The travel diaries of tetanus and botulinum neurotoxins. Toxicon 2018;147:58-67.
DOI
|
14 |
Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel) 2013;5:73-83.
DOI
|
15 |
Yen LM, Thwaites CL. Tetanus. Lancet 2019;393:1657-1668.
DOI
|
16 |
Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus surveillance--United States, 1998--2000. MMWR Surveill Summ 2003;52:1-8.
|
17 |
World Health Organization (WHO). Tetanus (total) reported cases [Internet]. Geneva: WHO; c2020. [cited 2020 Jul 15]. Available from: https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencettetanus.html.
|
18 |
Korea Centers for Disease Control and Prevention (KCDC). Infectious disease portal [Internet]. Cheongju: Korea Centers for Disease Control and Prevention (KCDC); c2020 [cited 2020 Jul 11]. Available from: http://www.cdc.go.kr/npt/biz/npp/ist/simple/simplePdStatsMain.do.
|
19 |
Perez-Fernandez J, Marin-Garcia G, Rodriguez-Vega G. Tetanus. In: Hidalgo J, Woc-Colburn L, eds. Highly infectious diseases in critical care. Cham: Springer; 2017. pp. 203-212.
|